Journal of Pharmacological Sciences
Published by The Japanese Pharmacological Society
Notice to Contributors
(Effective from August 2014)
Journal of Pharmacological Sciences is an international journal intended for the advancement of pharmacological sciences in the world. The Journal welcomes submissions in all fields of experimental and clinical pharmacology, including neuroscience, and biochemical, cellular, and molecular pharmacology of the 21 subject categories described below, for publication as Reviews, Full Papers, or Short Communications. All papers are subjected to peer-review. Manuscripts will be published within 2 months after their acceptance.
Submissions that have been published or accepted, or are under consideration for publication, with essentially the same content, will not be considered. This restriction does not apply to results published as an abstract, letters to editors, or as submissions for symposia, provided that the submission adds significantly to the information available in the previously published submission.
Conflict of Interest (COI) must be considered to prevent ambiguity about financial and personal relationships that might bias the submitted work. All authors are requested to disclose any actual or potential conflict of interest including any financial, personal, or other relationships with other people or organizations for the past one year prior to submission that could inappropriately influence, or be perceived to influence, their work. This disclosure must be included in the text of the manuscript under the Conflicts of Interest heading. If the authors have no conflicts of interest, they must state as much, for example: “The authors indicated no potential conflicts of interest.” For a general description of authorship and the conception of COI, please refer to the “Authorship and Contributorship” and “Conflicts of Interest” sections in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (https://www.doczj.com/doc/ee15950511.html,/index.html).
Manuscripts that reveal a lack of proper, ethical consideration for experimental animals or human subjects will not be accepted for publication. The Journal endorses the “Guiding Principles for the Care and Use of Laboratory Animals” approved by The Japanese Pharmacological Society and the “Recommendations from the Declaration of Helsinki”. All ethical conditions must be indicated in the manuscript; e.g., the procedures followed were in accordance with institutional guidelines; the study was approved by a relevant ethical review committee (for experiments using human subjects, a certificate of approval must be also provided at the manuscript submission); the human subjects gave their informed consent; etc.
Authors are requested to select two or three (in their order of priority) of the following subject categories to which the manuscript applies. For any study employing natural medicine materials (NMM) (the details for NMM are described later in the last paragraph of section 5. General Instructions), be sure to include the category of "Natural Medicine Matarials (NMM) with significant biological activities"in your selection:
1.Biogenic active substances
2.Receptors/Channels/Transport systems
3.Intracellular signaling
4.Biochemical and Molecular Pharmacology
5.Stem Cell Pharmacology
6.Pain Pharmacology
7.Peripheral nervous system pharmacology
8.Cardiovascular pharmacology/Hematology
9.Central nervous system pharmacology
10.Respiratory pharmacology
11.Renal pharmacology
12.Gastrointestinal pharmacology
13.Smooth muscle pharmacology
14.Bone and dental pharmacology
15.Endocrine pharmacology
16.Clinical pharmacology
17.Immunopharmacology/Inflammation
18.Biopharmaceutical Pharmacology
19.Chemotherapy
20.Toxicology
21.Natural medicine materials (NMM) with significant biological activities (req checklist)
Authors are required to suggest four reviewers who would be the most pertinent to review the submitted paper. Authors may also indicate up to three reviewers that they would like excluded from the review process. The ultimate selection of such reviewers is at the sole discretion of the editor.
Preparation of Manuscripts
Papers should be in standard English and be prepared in A4 (210 mm × 297 mm) page size, using standard fonts with size of 11 or 12, with double-spacing, and margins of at least 25 mm all around (desirably, 25 lines per page). The authors must strictly adhere to the proper format of the Journal for all sections of the manuscript; refer to papers in recent issues for the general layout of the paper and also for details. For authors whose native language is not English, the Journal strongly recommends brushing up the English of the manuscript by consulting an English-speaking scientist before submission to avoid delays in receiving and processing of the manuscript.
1.Full Papers
1)Title page — should include the complete title of the manuscript; full names of all authors; their affiliations and addresses; a running title (short title) of no more than 40 characters (including spaces); and the name and E-mail address of the corresponding author.
2)Abstract and keywords — 200 words presented in a concise form and including the purpose, general methods, findings, and conclusions of the research described in the paper. A list of 5 keywords or short phrases suitable for indexing should be typed at the bottom of the abstract page. Avoid vague or overly general terms. If necessary, the keywords will be adjusted to the standards of the Journal by the editors without consulting the authors.
3)Introduction — should give a short and clear statement of the relevant background and the rationale of the study.
4)Materials and Methods — should include explicit, concise descriptions of all new methods or procedures employed. Commonly used methods require only a citation of the original source. The description should be such that the reader can judge the accuracy, reproducibility, reliability, etc. of the work.
5)Results — should include experimental data but not extended discussions of its relative significance. Results are more easily grasped by readers if they are presented in graphic or tabular form rather than discursively. Data should not be repeated in the text, Tables, and Figures.
6)Discussion — should be pertinent to the results. Speculation is to be based on data only; be concise and clear. Lengthy discussions will necessarily mean a delay in accepting manuscripts for publication. The text should be written with a logical connection between the introduction and conclusions.
7)References — The format should be as described in 5. General Instructions.
Article Length: The main body of the text should ordinarily be less than 4,000 words from Introduction to References, and manuscripts should contain no more than 8 Figures and/or Tables and an abstract not exceeding 200 words. The manuscripts normally occupy 8 journal pages (e.g., about 24 typewritten pages including all components).
2.Short Communications are completed projects of smaller scope, but may not be used for preliminary publications of the data; therefore, the same material cannot be published elsewhere as an original paper. The main body of the text of these communications should be no more than 1,500 words in length, without any subheadings, and manuscripts should contain no more than 3 Figures and/or Tables and a maximum of 15 references. They should have an abstract not exceeding 100 words in length. The manuscripts normally occupy 4 journal pages (e.g., about 12 typewritten pages including all components). Provide a running title (short title) of no more than 40 characters (including spaces) in length and 3 keywords or short phrases for indexing (see 1. Full Papers). Indicate the number of words used in the main body of the text. Please refer to 5.General Instructions for references and other manuscript requirements.
3.Reviews will usually be written at the request of the Journal. Occasionally, unsolicited ones will be considered for publication; authors/organizers of such reviews should consult one of the editors, enclosing a one-page typed synopsis, before submitting the article. The unsolicited articles are subjected to rigorous assessment of their suitability for publication.
Five types of reviews will be considered:
1)Current Perspectives (up to 10 typewritten pages for the main body of the text and a maximum of 30
references; they will normally occupy 6 journal pages): These articles should provide insight into or comments on current directions of research on a topic and/or discuss potential new approaches to an area of investigation.
2)Critical Reviews (up to 40 typewritten pages for the main body of the text and a maximum of 100
references): These should cover a current topic of interest that has not been recently reviewed, emphasizing a critical discussion of noteworthy developments in the field; they should not be just a compendium of studies on the topic and should not be only autobiographical.
3)Survey Reviews (up to 60 typewritten pages for the main body of the text and a maximum of 300
references): Should be a comprehensive survey of the research on a topic that has not been recently reviewed.
4)Forum Minireviews (approx. 30 journal pages): One set of reviews is put together by an organizer(s)
on a particular topic; each set is composed of a maximum of 6 minireview articles (about 15 typewritten pages for all components of each manuscript, as a standard length; 4 – 5 journal pages, each) and a preface.
The topic and contributors should be based on one of the Symposia of the Annual Meeting of The Japanese Pharmacological Society or they may be occasionally based on Symposia of special interest to pharmacologists.
5)New Drugs and Recent Techniques (up to 60 typewritten pages for the main body of the text and a
maximum of 300 references): The purpose of these reviews is to introduce worldwide recently developed drugs and new techniques. These articles should be written in sufficient scientific detail and format to explain the characteristics of the drugs and/or promising techniques evaluating pharmacological actions.
Each manuscript should include an abstract, not exceeding 200 words, a running title (short title) of no more than 40 characters (including spaces) in length, and 5 keywords or short phrases for indexing (see 1. Full Papers). Please refer to 5. General Instructions for further details.
4.Correspondence (Letters to the Editor): The Journal will occasionally consider publishing letters to the editor from readers and authors in the “Correspondence” section. Letters should be comments and clarifications on articles that have recently been published in this Journal and be in a concise form. The text of these Correspondences should be no more than 2,000 words in length, without any Figures and/or Tables and a maximum of 10 references. When necessary, please refer to
5. General Instructions.
5.General Instructions
References — should be cited in the text by number, in parentheses, in line with the text; the full reference is cited in a numbered list at the end of the paper. The reference list should be prepared with the authors’ names (list all authors if six or less; otherwise, list the first six followed by et al.), full title of paper, journal, year of publication, volume, and initial and final pages.
e.g., Mizuno M, Iwakura Y, Shibuya M, Zheng Y, Eda T, Kato T, et al. Antipsychotic potential of
quinazoline ErbB1 inhibitors in a schizophrenia model established with neonatal hippocampal lesioning. J Pharmacol Sci. 2010;114:320–331.
References to books should include the authors’ names, title of article, editors, title of book, edition, city where the publisher is located, publisher, year of publication, and initial and final pages of the cited article or section.
e.g., Zhao Q, Holmes GL. Repetitive seizures in the immature brain. In: Pitk?nen A, Schwartzkroin PA,
Moshé SL, editors. Models of seizures and epilepsy. 2nd ed. San Diego: Academic Press; 2006. p.
341–350.
For formats of other published materials, please refer to the Vancouver style (see the “References” part of the “Manuscript Preparation” section in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (https://www.doczj.com/doc/ee15950511.html,/index.html).
Papers are not to be cited as “in press” unless they have already been accepted for publication. In such cases, state the name of the journal and provide the accepted manuscript.
Figures and Tables — should be numbered consecutively with Arabic numerals, with each one displayed on a separate page. These usually will be reduced to fit a single column, 8.8-cm-wide, or at most, a double column, maximally 18.3-cm-wide.
Any color Figure submitted by the authors will be processed with the understanding that upon acceptance of the manuscript, the Figure must be published in color online without any additional charge to the authors.
Abbreviations and Units — while authors should avoid unfamiliar abbreviations, a limited number of clearly defined abbreviations may be used. Such abbreviations must be defined at the first mention in the text or defined in alphabetical order in a footnote on the first page. When in doubt, avoid unfamiliar abbreviations. For units, the Journal recommends the use of the International System of Units (SI Units). It is desirable to refer to standard abbreviations and units listed in the Instructions to Authors of the Journal of Biological Chemistry (https://www.doczj.com/doc/ee15950511.html,/misc/ifora.xhtml).
Drugs — Generic names should be used in the text, Figures, and Tables.
Electronic Supplementary Materials — Although manuscripts must be complete and self-explanatory without supplementary information, m aterials that cannot be presented on the journal pages for reasons of space or format restrictions may be published online as supplementary materials without any additional charge to the authors. Background information regarding experimental procedures may also be included. T hese additional or secondary materials are subject to the same peer-review process as the rest of the manuscript and must be cited in the main text. File sizes must be as small as possible so that they can be downloaded quickly. Acceptable formats for movie and sound are: mpg, mov, avi, mp3, and wav. For more detailed instructions please visit the artwork instruction pages at
https://www.doczj.com/doc/ee15950511.html,/artworkinstructions.
Guidelines for manuscripts concerning natural medicines — Here, “natural medicines” mean any extract(s) or unpurified constituent(s) obtained from natural sources (natural medicine materials: NMM). Studies discussing NMM should comply with the Guidelines/Checklist of the Journal shown later; authors MUST provide the completed checklist for NMM upon manuscript submission. Manuscripts concerning simple screening of biological activities of the NMM and/or studies that do not meet the NMM guidelines stipulated in the Checklist for the NMM are likely to be rejected without review.
Consult the “Author’s Checklist for Manuscript Submission” that appears on the final page of these instructions for a more detailed explanation of the requirements on the manuscript preparation.
Submission of Manuscripts
Manuscripts should be submitted via the online manuscript submission review, and tracking system “Editorial Manager?” at https://www.doczj.com/doc/ee15950511.html,/. We will not accept any manuscripts submitted as an E-mail attachment or by post. Before entering the submission web site, please refer to this “Notice to Contributors” including “Author’s Checklist for Manuscript Submission” for overall guidelines for how your manuscript should be structured and formatted. Then, be sure to refer to the “Tutorial for Authors” available at the submission web site, which will provide you with more detailed, technical, and other important information.
Brief guidelines for electronic submission procedures
1)Prepare the text (title page, abstract, main text, references, legends for Figures, and Tables) by MS-Word;
be sure to insert page numbers. Tables can be prepared with a separate file.
2)Prepare the Figures using applications that are capable of generating high-resolution files. The Figure
number must be indicated on each Figure itself, outside the image area.
*Compatible data files (such as Figure, Table, text) for Electronic Supplementary Materials must be prepared
in the same manner.
3)Login as an author to Editorial Manager?. You are required to have your login ID. If you do not have one,
you can easily get an ID by registering your name and E-mail address.
4)Click “Submit New Manuscript” and enter required information [article type, title and short (running) title,
authors, abstract, keywords, classification (1 or 2 subject category(s)), additional information (COI, statement of originality, confirmations of the author’s checklists / NMM checklist / color Fig(s)), four suggested reviewers, comments, etc.)] into the web pages.
5)On the “Attach File” page, upload the files by selecting the appropriate entry item such as i) Manuscript,
ii) Table(s), iii) Figure(s), iv) Movie(s), v) Others (for review), vi) Others (not for review). Items i, ii, and iii will be built into a single PDF; items iv and v will be accessed via PDF with links; item vi will not be included in PDF, but will be accessible to the Editorial Office and Editor only as a companion file. Item v may include the COI statement; a certificate of approval issued by the ethical committee for experiments using human subjects; an “In Press” article to be referred to; or appended data/information necessary for the manuscript such as papers discussing natural medicine materials (NMM); supplementary materials other than those falling under categories ii – iv.
6)After uploading the files, you will be requested to approve the formatted PDF. Return to the main menu
and APPROVE your submission accordingly.
-----------------------------------------------------------------------------------------------------------------------------------
The editors reserve the right to make minor revisions in manuscripts accepted for publication in the interest of clarity, consistency, and readability. However, they cannot accept responsibility for opinions expressed by contributors.
After Acceptance
The copyright: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' where authors will retain copyright (for more information on this see
https://www.doczj.com/doc/ee15950511.html,/OAauthoragreement.).
Retained author rights: As an author you (or your employer or institution) retain certain rights, including copyright; for details you are referred to https://www.doczj.com/doc/ee15950511.html,/OAauthoragreement.
Role of the funding source: You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Funding body agreements and policies: Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit https://www.doczj.com/doc/ee15950511.html,/fundingbodies.
Open access: This journal is fully open access; all articles will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by the following Creative Commons user license: Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
If you need to comply with your funding body policy you can apply for a CC-BY license after your manuscript is accepted for publication.
Publication Fees (the indicated price does not include the domestic consumption tax):
?The following publication Fees are charged to the authors with the JPS membership.
Full Paper (limit 8 pages): JPY 75,000
Review type article (limit 8 pages): JPY 75,000
Short Communication (limit 4 pages): JPY 35,000
Correspondence (limit 4 pages): JPY 35,000
Extra page charge exceeding the limit pages: JPY 10,000 per page
?The following publication Fees are charged to the authors without the JPS membership.
Full Paper (limit 8 pages): JPY 100,000
Review type article (limit 8 pages): JPY 100,000
Short Communication (limit 4 pages): JPY 50,000
Correspondence (limit 4 pages): JPY 50,000
Extra page charge exceeding the limit pages: JPY 10,000 per page
*If you wish to join JPS, please contact the membership office at jps@imic.or.jp .
Annual membership fee for a general member is JPY 9000, for a graduate student is JPY 6500, and for
a student is JPY 3000.
Once you become a member of JPS before your author proof, your publication fee is charged as a JPS member.
?Invited articles are exempt from the charges.
?Authors are responsible for the costs of a corrigendum (JPY 10,000 per page).
?The fees are charged to authors after acceptance. Articles are not published until the required payments are fully paid online. If author fails to do so within (2) months of the payment notice, the paper may be withdrawn from the journal publication service.
Use of the Digital Object Identifier: The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.
Proofs: One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 9 (or higher) available free from
https://www.doczj.com/doc/ee15950511.html,/reader. Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
https://www.doczj.com/doc/ee15950511.html,/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
Offprints: The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail (the PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use). Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop (https://www.doczj.com/doc/ee15950511.html,/myarticleservices/offprints).
Accepted Articles: Visit https://www.doczj.com/doc/ee15950511.html,/authors for the facility to track accepted articles and set email alerts to inform you of when an article s status has changed. The website also provides detailed artwork guidelines, copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those related to proofs, are provided after registration of an article for publication.
Editorial/Publishing Correspondence:
Journal of Pharmacological Sciences Editorial Office:
Elsevier Japan KK
1-9-15 Higashi Azabu, Minatoku, Tokyo 106-0044 Japan
Tel: +81 (0)3 3589 5037 / Fax: +81(0)3 3589 6364
jps.editorialoffice@https://www.doczj.com/doc/ee15950511.html,
Journal information: https://www.doczj.com/doc/ee15950511.html,/journal-of-pharmacological-sciences/
Abstract/Full text online:
http://www.jstage.jst.go.jp/browse/jphs/ (issues after 2003)
http://www.jstage.jst.go.jp/browse/jjp/ (issues before 2002)
https://www.doczj.com/doc/ee15950511.html,/science/journal/13478613 (issues after 2015)
Submission online “Editorial Manager?”: https://www.doczj.com/doc/ee15950511.html,/
Guidelines/Checklist for authors submitting papers discussing Natural Medicine Materials (NMM) to the Journal of Pharmacological Sciences
(Effective from January 2008) Experimental procedures and manuscript preparation must comply with the proceeding requirements. Please upload the completed checklist and required supplemental data/information on the “Attach File” page of the web submission system.
Check each bracket upon completion
1. Description of the NMM being studied
[ ] Provide Latin names, nomenclature author, and family name (in parentheses) for all collected materials used in the current study.
2. Source of the NMM used in the study
[ ] In the case that the NMM used in the current study is collected in the field or acquired at a local market(s), the collection site(s) and the name(s) and affiliation of the person(s) identifying the material(s) should be indicated in the manuscript.
[ ] If the NMM/NMM extract(s) used in the study is purchased from an industrial source(s), the name of the manufacturer(s) and lot number of the material(s)/extract(s) should be indicated.
3. Specimen number and depositing of the NMM
[ ] Indicate the specimen number(s) of the NMM being studied and the name of the affiliation/organization where these specimens are deposited.
[ ] The specimen(s) used in the study should be stored for 10 years in the affiliation/organization to permit future reference and verification.
This information will allow the NMM to be used by other researchers should requests be made.
4. Extraction methodology and chemical profiling of the NMM
1)
[ ] The detailed method of extraction (i.e., solvent, temperature, and time) and the yield of extracts should be clearly indicated in the manuscript.
[ ] Chemical profiles of the NMM extract must be provided; this is usually done by means of an HPLC fingerprint or quantitative analysis of known components. When the bioactive constituents in the extracts are unknown, a qualitative analysis with HPLC or TLC may be acceptable.
[ ] Chemical characterization of the NMM extract(s) should be conducted by using marker substances that are characteristic to the NMM used in the study, but not ubiquitously distributed in nature.
2)
[ ] In the case that the extraction methodology and chemical profiling of the NMM extracts used in the study have previously been reported by the authors in a peer review journal(s), detailed information can be substituted by providing a brief explanation along with authors’ references.
A chemical profile of the NMM extract and detailed explanations about it should be clearly indicated in the manuscript or should be provided to the editor along with the manuscript. That being said, this information needs to be reviewed for publication in the Journal.
5. Elucidation of pharmacological activities of the NMM being studied
[ ] To evaluate pharmacological efficacy of the NMM extract(s), a standard drug(s) should be simultaneously evaluated as a reference (positive control).
[ ] The in vitro activity of an extract should be detected at concentrations lower than 100 microgram/ml.
Use of reference medications will facilitate comparison of the efficacy of the NMM to established standard drugs. With such data, the readers can better appreciate the efficacy and underlying mechanism of the NMM under study.
I declare that our manuscript submitted to the Journal of Pharmacological Sciences has been prepared according to the guidelines described above.
Signed ( ) Date ( )
Journal of Pharmacological Sciences
Author’s Checklist for Manuscript Submission
(Effective from August 2014)
Please consult the “Notice to Contributors” and complete the following checklist so that your manuscript will conform to the style and usage of the Journal of Pharmacological Sciences before submission.
[ ] Title page
–title: avoid using the trade name of a drug / should not contain abbreviations except for very standard ones / should indicate the experimental animal / a drug for which a generic name has not yet been given can be designated by a combination of letters and numbers only when accompanied by a specification of its pharmacological property (e.g., anti-allergic drug, AB-123)
–provide full names of all authors / provide affiliations and addresses of all authors / identify each author with the appropriate address by numerical superscripts
–provide the corresponding author’s information including e-mail address, telephone number, and fax number. –provide a running title (short title) of no more than 40 characters and spaces
–indicate the number of words used in the main body of the text
–provide any necessary footnotes (e.g., change of address)
[ ] Abstract page
–limit Abstract to 200 words for Full Paper and Review, 100 words for Short Communication
–do not cite references in Abstract by reference numbers, but use full citation; omit the article title
–provide keywords: 5 items for Full Paper and Review, 3 items for Short Communication / avoid vague or overly general terms
[ ] Text
–main- and subheadings: refer to current style in this Journal
–drug names: use generic names; if a generic name has not yet been given, provide the full chemical name at the first mention
–ionic charge should be shown throughout (e.g., Ca2+ channel)
–provide names of sources including city, state (USA), and country (except for Japan) for experimental apparatuses, reagents, animals, and cell strains
–all ethical conditions for experimental procedures should be clearly described in the Materials and Methods section
–unpublished data, personal communication, etc. in the text: specify the source of the information (e.g., Y.
Yamada et al., unpublished data)
–disclose, if any, authors’ financial interest in the subject matter or relationship with other people and organizations with such financial interest in the Conflicts of Interest section
[ ] References –refer to current issues–
–list references in numerical order according to the first mention in the text
–“in press” citation must have been accepted for publication; designate journal title
–“unpublished observations”, “personal communication”, “submitted manuscript”: do not list in “References”, but insert in appropriate places in the text with source name
–“encyclopedia”, “patent”, and “thesis” are not valid reference citations
–state “(text in [specify language used] with English abstract)” for a paper with text written in languages other than English but with English abstract
–avoid citing any paper written in a language not normally used for international scientific publications (including Japanese) and does not have an English abstract; if you must cite such a reference, state your justification for including this reference, on a separate sheet; and specify the language in the reference list
[ ] Figures and their legends –refer to current issues–
–supply Figs. of sufficient quality for direct printing
–all Figure elements (letters, numbers, and symbols, etc.) should be sufficiently large and clear so that they can be easily read after reduction
–in Fig. legends, do not use the pictorial representation of the actual graphic symbols themselves or actual patterns, but describe them in words (e.g., closed circle, dotted column) or commonly usable marks (e.g., *, #); alternatively, give the explanations of symbols/patterns on the Figs., if representing them pictorially –magnification of electronmicrographs should be indicated by a calibration bar on the photographs themselves to ensure that, after any necessary reduction, the scale is reduced in the correct proportion
–symbols indicating statistical significance: the number of symbols used to indicate a particular probability (P value) should be consistent throughout the manuscript; the same probability should be represented by the same number of symbols in the Figs. and Tables, and the number of symbols should increase as the P value decreases
–avoid unnecessary three-dimensional representation of data in bar graphs
–type legends for Figs. double-spaced on a separate page
–for a Fig. consisting of separate panels: do not provide a separate title for each panel, but rather provide one comprehensive title; explanations of panels to be provided in the legend following the title
[ ] Tables and their footnotes –refer to current issues–
–type each Table double-spaced on a separate page; do not insert in the running text
–type a brief informative title above the Table and footnotes at the foot of the Table
–do not use vertical lines to separate columns
-----------------------------------------------------------------------------------------------------------------------------------
[ ] Full Paper
–Abstract of 200 words or less
–main body of the text of 4,000 words or less (on the title page, indicate the number of words used)
–no more than 8 Figs. and/or Tables
[ ] Short Communication
–to determine if your study is appropriate for publication as a Short Communication, carefully read the Notice to Contributors
–type text without subdivision into sections
–Abstract of 100 words or less
–main body of the text of 1,500 words or less (on the title page, indicate the number of words used)
–no more than 15 references
–no more than 3 Figs. and/or Tables
Other manuscript requirements: see items shown above (from Title page to Tables sections)
Notice to Authors of JACS Manuscripts 稿件提交要求及注意事项 ?当一篇稿件提交至JACS后，编辑会对这篇稿件做一个初步的筛选，以判断这篇稿件是否适合此期刊的读者，大部分的稿件会在这个阶段被退回。 ?文章的题目不能包含“First”，“Novel”这类词或任何数字或号码形式。 ?标题中不允许用缩写，除非是通识的缩写 ?文章的题目、作者列表及作者的排序都应与提交的稿件保持一致。 ?所有作者的姓名应列入提交页面，同时须提供当前的每一个联系信息和直接的/有效的电子邮件地址。 ?Communications和Articles须在手稿文档文件中包含摘要和目录（TOC）?Communications 文章必须使用现有的communication 模板，篇幅不超过4页。 ?文章要正确标记所有部分（介绍、讨论、实验部分及结论等）。 ?在提交文件前请取消“track changes”；上传的注释文件Supporting Information仅供审查工作。 ?无论是“In press”、“accepted”或“submitted”等的相关发表稿件副本需在发表或者其他准备阶段中上传提交稿件Supporting Information以供审查。只有被Digital Object Identifier（DOI）引用参考文献才可以被引用。。 ?所有PDF的Supporting Information页面应依次编号。CIF和txt文件的页面不需要编号。?在手稿文件中可能不包含Supporting Information，供文章发表或只供编辑审稿Supporting Information需要单独上传。。 ?可以声明贡献基本相同的作者；逐条记载作者的个人贡献或部分著作权是不允许的。 ?不鼓励使用过多的自引。 ?在JACS稿件或Supporting Information中不能包含免责声明。 ?附录可能只出现Supporting Information中，而不出现在稿件中。 ?商标的物品（公司或机构的标识，图像，和产品）和图像从网上下载是不允许的，所有的图形都是经编辑审批。 ?如果要发布新的晶体信息，文件必须在Supporting Information中使用CIF格式编辑，即使这些晶体信息文件已经提交给CCDC,ICSD或PDB。 ?表达谢意也许只能出现在致谢部分且须经编辑批准。 ?接受日期为编辑办公室记录接收完稿日期。准备进行审阅的稿件，首次提交时，将由副主编进行初步处理。 ?文章首先在ACS网络上发表的日期将被记录为发表日期——最早是“Just Accepted”, “Articles ASAP”, 或发表日期。 ?发表期刊需要有出版协议。作者强烈建议使用电子期刊出版协议。如果使用的是PDF版本，所有签署协议的页面必须以TIF或PDF格式上传到ACS Paragon Plus Environment 或通过电子邮件、传真或邮件到制定的副主编。 ?未能遵守一个或更多的ACS Ethical Guidelines to Publication of Chemical Research将会造成纪律处分。 范围和编辑政策 Initial Editorial Review：介绍了JACS主要接收化学领域原创的，有重大突破的文章。Manuscript Submission：稿件提交只能通过ACS Paragon Plus Environment系统，并且
《中华护理杂志》 编辑部投稿须知指南 期刊简介：《中华护理杂志》为中华护理学会主办、国内外公开发行的综合性护理学学术期刊，主要报道护理学领域领先的科研成果和临床经验，以及对护理临床有指导作用的护理理论研究。本刊的办刊宗旨是：贯彻党和国家的卫生工作方针政策，贯彻理论与实践普及与提高相结合的方针，反映我国护理临床科研工作的重大进展，促进国内外护理学术交流。 刊名：《中华护理杂志》，英文：《Chinese Journal of Nursing》。主办单位：中华护理学会。编辑单位：《中华护理杂志》编辑委员会；《中华护理杂志》编辑部。地址：北京市朝阳区十里堡甘露西园1号楼314室。邮政编码：100025。电子邮件：zhhlzz@https://www.doczj.com/doc/ee15950511.html, 。国际刊号：0254-1769。国内刊号：11-2234/R。期刊种类：月刊。 栏目设置：本刊辟有论著、临床护理研究、护理管理、护理教育、专业化教育与培训、综述、中医护理、基础护理、医院感染控制、手术室护理、探索与争鸣、研究生园地，社区护理、论坛、国外护理评介、经验与革新、编读往来、中外护理动态、护理史话、人文织锦等栏目。 《中华护理杂志》是中国科技论文统计源期刊、中国生物医学核心期刊中国临床医学类核心期刊。至2007年底已连续六届荣获“百种中国杰出学术期刊”称号。《中华护理杂志》系中华临床医学会主办的临床护理专业期刊，中文版每
月30日出版一期。热忱欢迎广大读者踊跃投稿和订阅。 一、投稿要求和注意事项 1、文字要求。来稿应具先进性、科学性和逻辑性，要求资料真实、数据可靠、论点明确、结构严谨、文字通顺。论著、综述类一般不超过5000字，经验交流不超过3000字，简报、病例报告不超过2000字。邮寄稿件请作者以A4纸张打印并核对清楚，尤其标点符号，标点符号占一格，英文应隔行打印。为提高审稿效率，条件允许的作者请优先选择电子邮件的方式投稿。不准一稿多投，文责自负，自留底稿，一律不退。 2、稿件处理。编辑部对来稿及时进行处理，一般在接稿后一周内将“稿件受理通知”通过电子邮件发送给第一作者或通讯作者。若作者投稿15日后仍未接到“稿件受理通知”请即来E-mail咨询。编辑部对来稿有删修权，不同意删修者必须来E-mail声明。实验研究、新技术研究类优越稿件酌致稿酬。本刊大16开，月刊，稿件容量大，发表周期短，一般不超过30个工作日。凡在接到本刊受理回执后1个月内未接到稿件终审通知者，系文章仍在排队审理中。凡投寄本刊的稿件，2个月内（以稿件受理回执日期计算）给予回复审稿意见。未经录用稿件，允许作者提出不同意见。本刊不退原稿，请作者自留底稿。作者如欲投他刊，请先与本刊联系，切勿一稿两投，耗费专家评审精力。 3、投稿方式。电子邮件投稿（即网络投稿）请用Word格式的附件来邮；邮寄来稿请尽量用小四号字打印在A4纸上，凡字迹潦草、涂改不清的稿件，恕
《 》杂志投稿须知 《药物评价研究》杂志是中国科技核心期刊（中国科技论文统计源期刊）、RCCSE 中国权威学术期刊，由中国药学会和天津药物研究院共同主办，2017年起变更为月刊，国内外公开发行。本刊的办刊宗旨为：报道药物评价工作实践，推动药物评价方法研究，开展药物评价标准或技术探讨，促进药物评价与研究水平的提高，为广大药物研究人员提供交流平台。针对药物及其制剂的评价规范以及药学评价、安全性评价、药效学评价、药物代谢动力学评价、临床评价、上市药物评价等评价研究的内容，设置论坛、综述、方法学研究、试验研究（论著）、审评规范、国外信息、专题等栏目。《药物评价研究》杂志目前已被CNKI 中国期刊全文数据库、万方数据库、波兰《哥白尼索引》（Index of Copernicus ，IC ）、美国《乌利希期刊指南》（Ulrich's Periodicals Directory ，Ulrich PD ）、美国《化学文摘（网络版）》（Chemical Abstracts ，CA ）、英国国际农业与生物科学研究中心（CABI ）等收录，并由中国知网独家全文发布和优先出版。 1 投稿要求 1.1 介绍信 投稿须附单位主管学术部门的介绍信（综述文章除外），注明内容真实、无一稿两投、署名无争议、无泄密内容。已在非公开发行的刊物上发表或学术会议交流过的必须注明。 1.2 投稿方式 本刊采用在线投稿、审稿、查询系统，作者可登陆www.中草药杂志社.中国或https://www.doczj.com/doc/ee15950511.html, 投递、查询稿件，不接受纸质投稿。 1.3 医学伦理问题及知情同意 若论文的主题是以人为研究对象，作者应提供单位性的、地区性的或国家性的伦理委员会的批准文件及受试对象或者其亲属的知情同意书。 2 文稿的撰写要求 2.1 文题 每篇来稿均要有中英文题名。中文题名一般不超过20个汉字，应以简明、具体、确切的词语，概括文章的要旨，符合编制题录、索引和检索的有关原则，并有助于选择关键词和分类号。题名中应避免使用非公知公用的缩写词、字符、代号以及结构式或公式。英文题名首字母大写，其他均小写，英文题名中不用冠词，并应与中文题名含义相一致。 2.2 作者及工作单位 作者姓名在文题下按序排列，应限于参加研究工作并能解答该文有关问题及对文稿内容负责者。若第一作者或第一单位有变动，应有单位证明信。对论文有贡献的其他人员如 协助工作或提供资料、材料者可放在致谢项。姓氏的汉语拼音字母全部大写，复姓应连写；名的首字母大写，双名中间加连字符。工作单位名称列于署名之后，用全称，不用简称或缩写，工作单位后写出所在省、市及邮政编码，并附单位英文名称，应与中文单位名称对应。通信作者用“﹡”标出，并在论文首页脚注通信作者姓名、E-mail 地址等联系方式。英文摘要中的作者工作单位还应在城市名称及邮政编码之后加列国名，其间以“，”分隔。 2.3 地脚线 ①收稿日期：由本部填写收稿的具体日期。②基金项目：应注明国家有关部门的正式基金名称的全称及编号。③作者简介：第一作者姓名（出生年—）、性别（民族，汉族可省略）、籍贯、职称、学位及研究方向，并提供详尽的联系方式（电话、传真、E-mail 等）。④通信作者 姓名及联系方式。 2.4 摘要和关键词 文稿需附加中、英文摘要和关键词。中文摘要一般不超过400字，关键词5～8个，中、英文需对应。关键词尽量选用《汉语主题词表》和《中医中药主题词表》中的规范词，主要的自由词和未被词表收录的新学科、新技术中的重要术语也可作为关键词标出。多个关键词之间用“；”分隔。研究性论文的中、英文摘要均采用四要素结构式书写，即目的（Objective ）、方法（Methods ）、结果（Results ）和结论（Conclusion ）。综述性论文需写出指示性摘要，中文200字左右。英文文题、关键词及作者名称和单位须与中文对应。 2.5 正文 一般应包括以下几个部分：①引言；②材料和方法；③结果；④讨论；⑤参考文献。正文应层次分明，在层次标码后，应拟定标题。尽量减少层次，不得多于3层，采用1，1.1，1.1.1方式。层次的数字序号顶格写，序号后要空一个汉字。 2.5.1 引言 一般不超过250字，概述本研究的理论依据、思路、实验基础及国内外现状，并应明确提出论文研究的目的。 2.5.2 材料和方法 清楚地描述观察或实验对象的选择情况，详细实验方法、仪器（注明制造厂商）及步骤，以便他人重复验证。列出建立方法的文献，其中包括统计学方法的文献。对已发表但尚未为人们所熟悉的方法，要提供简要的描述和文献；对新的或有实质性改进的方法要详细介绍并对其限度加以评价。准确说明药物和化学品的使用方法，包括商品名称、剂量以及给药途径。 病理号、药品批号、仪器型号、所用动物的清洁度、种系等均应列出。药名符合《中国药品通用名称》及《国际非
《中华肾脏病杂志》投稿须知 信息来源：作者：发布时间：2015-1-17 《中华肾脏病杂志》是由中国科学技术协会主管，中华医学会主办，为我国内、儿科肾脏病学科领域最高水平的专业期刊，中山大学出版并向国内外公开发行的肾脏病学的专业学术期刊，同时也是中华医学会肾脏病学分会的专业性学术期刊。对促进肾脏病学术交流及发展起着重要的指导作用。中国科技期刊引证报告显示，本刊被引频次和影响因子均名列同类杂志之首，已成为国内较有影响力的核心期刊之一。《中华肾脏病杂志》创办于1985年，月刊，规格为国际通用的大16开本，由《中华肾脏病杂志》编辑委员会编辑，中华肾脏病杂志编辑部出版，国际标准刊号ISSN1001-7097，国内统一刊号CN44-1217/R，邮发代号：46-106，单价：12.00，全年定价：144.00。 《中华肾脏病杂志》是国内肾脏病领域学术影响力和发行量最大的期刊。现为全国中文核心期刊（北大1992、1996、2000、2004、2008版中文核心期刊目录（医药卫生类））, 是中国科技论文统计源期刊（2008年版中国科技论文统计源期刊），已被CA 化学文摘(美)(2009),CBST 科学技术文献速报(日)(2009),中国科学引文数据库(CSCD—2008)数据库和检索系统收录。 1．论著一般不超过5000字(包括摘要、图表及参考文献)；讲座、综述、会议纪要、临床病理(例)讨论类文稿字数可视具体情况而定；短篇论著(论著摘要)、病例报告等不超过2000字。 2．推荐信：来稿需经作者单位审核，并附单位推荐信。推荐信应注明对稿件的审评意见以及无一稿两投、不涉及保密、署名无争议等项，并加盖公章。如涉及保密问题，需附有关部门审查同意发表的证明。 3．投稿清单：(1)单位介绍信(推荐信)、医学伦理知情同意书；(2)题名及作者，作者单位，基金资助项目，项目负责人，Email，电话，传真，投稿日期；(3)中文摘要；(4)英文摘要；(5)正文：引言，材料与方法，结果，讨论，志谢，参考文献(视文章体裁选择相关项目)。 4. 投稿方式：从2007 年1月起，本刊将启用电子投稿：zhszbqk@https://www.doczj.com/doc/ee15950511.html,，全面试行网上投稿、网上审稿、网上查询等方面的工作。欢迎广大作者进行投稿和查询。 电子版：为了便于专家网上操作，同时需要提供文章的电子版（远程或E-mail ）。电子版要注意查看下大小，如果超过5M，建议分部分发送到编辑部邮箱；如果特大，则建议对高分辨率图片进行一定的压缩，具体压缩方式为：首先图片要粘贴到Word里面，鼠标点图片，右键，设置图片格式，左下角有个“压缩”，点击它就可以把10几个M的图片压缩为几百K。对于有高要求的图片，建议刻录光盘寄送到编辑部。发E-mail时，务必要注明作者姓名，有稿号时也要注明稿号，每天邮件较多，这样可以方便查找。 5．医学伦理问题及知情同意：当论文的主体是以人为研究对象时，作者应说明其遵循
ONE TABLE OF CONTENTS Select an item in the table of contents to go to that topic in the document. LOGGING ON AND OFF THE AUTHOR CENTER (2) LOGGING ON (2) LOGGING OFF (3) FORGOT YOUR PASSWORD? (3) HELP DOCUMENTATION (4) THE WELCOME PAGE (4) INSTRUCTIONS AND FORMS (4) THE AUTHOR DASHBOARD (5) THE MANUSCRIPT SUBMISSION PROCESS (5) IMPORTANT NOTES (6) STEP 1 – TYPE, TITLE, & ABSTRACT (7) SUBMITTING AGENT QUESTION (8) STEP 2 – ATTRIBUTES & KEYWORDS (8) STEP 3 – AUTHORS & INSTITUTIONS (9) STEP 4 – REVIEWERS & EDITORS (10) STEP 5 – DETAILS & COMMENTS (12) STEP 6 – FILE UPLOAD (13) ZIP FILES AND LATEX DOCUMENTS (14) STEP 7 – REVIEW & SUBMIT (15) TIPS FOR AUTHORS SUBMITTING A REVISION (16)
LOGGING ON AND OFF THE AUTHOR CENTER LOGGING ON Each journal’s ScholarOne Manuscripts site has a unique Web address (URL). Typically, you are given the address in an email sent by the journal. If the address is hyperlinked, select the link within the email, or copy and paste into the browser. The journal’s Log In page is displayed. Access to the journal site may be provided in two ways: 1.The journal may create your account and email to you instructions on how to log in and set your User ID and password. 2.Some journals allow their users to create their own accounts. If yours does, there will be a Create Account link in the top right corner of the page, or you can use the New User? Register here just to the right of the Log In. Follow the 3-step process for creating your account. ?Journal-required fields are denoted by the required symbol
英文文献|英文期刊数据库|英文硕士论文|英文博士论文论文写作资源SCI论文润色北大核心期刊SCI影响因子 化学类英文期刊投稿指南 [学术须知] 专业SCI论文修改服务：★先修改后付款；☆语言问题免费重修；★24-72小时交稿；☆正规财务发票；★一分钟下单；☆365日不间断服务 化学类英文期刊投稿指南: 化学类（Chemistry） 1【期刊名称】SENSORS AND ACTUA TORS B: CHEMICAL 【所属学科】化学 【级别】SCI、EI 【期刊主页】https://www.doczj.com/doc/ee15950511.html,/wps/find ... ription#description 【投稿方式】email 【出版商】elsevier 【审稿周期】3-6 months 2【期刊名称】Applied Catalysis A: General 【所属学科】化学，催化 【级别】SCI、EI 【投稿主页】https://www.doczj.com/doc/ee15950511.html,/Jour ... 856&Precis=DESC 【投稿方式】online submision 【影响因子】2.337 【出版商】elsevier 【审稿周期】3 months 【出版周期】half-month journal 3【期刊名称】Tetrahedron Letter 【所属学科】有机化学Organic Chemistry 【级别】SCI 【期刊主页】https://www.doczj.com/doc/ee15950511.html,/sci ... c26274c4b9df99e5c0f 【投稿方式】email 【出版商】elsevier 4【期刊名称】Tetrahedron 【所属学科】有机化学Organic Chemistry 【级别】SCI 【期刊主页】https://www.doczj.com/doc/ee15950511.html,/wps/find ... ription#description 【投稿方式】email 【出版商】elsevier 5【期刊名称】The Journal of Organic Chemistry
《国际贸易问题》投稿须知（官方认证） 为进一步规范《国际贸易问题》杂志的学术论文格式和投稿流程，特对作者投稿做以下说明。 一、为了节约资源，提高审稿效率，本刊自2012年9月起不再接受纸质投稿，只接受电子版稿件，请发至本刊专用收稿邮箱：gjmywtqk@https://www.doczj.com/doc/ee15950511.html, 。此外，本刊编辑部郑重声明，对发给编辑部工作人员或请他人转寄的稿件将不予接受。 二、本刊提倡简洁朴素的文风，文章标题限20字之内，一般稿件正文原则上限8000~10000字。来稿请附中英文标题、中英文关键词（3-8个）、300字以内的中英文摘要及符合我刊格式规范的参考文献。作者文责自负。 三、作者应重视论文开头文献研究综述的写作，应该对自己所阐述的观点及其观点的准确性承担最终责任，这些观点不代表对外经济贸易大学的观点，也不代表《国际贸易问题》主编及编委会的观点。 四、文章正文一般用宋体五号字，标题一级序号为一、二、三，二级序号为（一）、（二）、（三），三级序号为1.、2.、3.，四级序号为（1）、（2）、（3）。引言不排序号。 如果引用的是论文中的观点，其写法为： “一段观点或结论（姓名，YYYY）”，或：“姓名（YYYY）的观点是……”。其中，YYYY是4位数的年号。如果作者在该年发表2篇以上的文章，则按照发表的时间顺序分别标注a、b、c等，如：YYYYa，或YYYYb。 图应标明图序和图题，序号和图题之间空1字，居中排于图的下方；资料（数据）来源标注于图左下方，图一般随文编排，放在相关文字的段后。 表格应标明表序和表题，序号和表题之间空1字，居中排于表的上方；资料（数据）来源标注于表格左下方，表格一般随文编排，放在相关文字的段后。
https://www.doczj.com/doc/ee15950511.html,/infman/登录系统 https://www.doczj.com/doc/ee15950511.html,/wps/find/journaldescription.cws_home/505553/authorinstructions 用户投稿手册 Use of wordprocessing software It is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format.Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, u se only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: https://www.doczj.com/doc/ee15950511.html,/guidepublication). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork. To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your wordprocessor. Article structure Authors should use a scientific/engineering attitude towards their analyses. The numbers computed should have the appropriate number of significant figures. Please do not use more significant figures than the observations allow (i.e., for most surveys 2 or 3 are sufficient). Decimal fractions should have a leading zero, e.g. 0.001 rather than .001 Authors are encouraged to look at the articles recently published inthe journal to understand the aims of the journal. Essential title page information ? Title.Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible. ? Author names and affiliations.Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and,if available, the e-mail address of each author. ? Corresponding author.Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that
《中国公共卫生》杂志作者投稿格式要求 一、文题 1.文题用2号黑体字居中通栏排版。 2.如是基金项目文章，文题末右上角加“﹡”号。 二、作者姓名 1.作者姓名用5号楷体居中排列在文题下方。 2.作者中单姓单名者姓与名之间不留空格，各姓名之间用“，”隔开。作者单位不同时，在作者姓名后的右上角以阿拉伯数字进行标注。 3. 作者姓名与中文文题的行间距空5号字1行 三、摘要与关键词 1.中英文摘要和关键词通栏排，两边各缩进2字格。英文摘要排在中文摘要下方，中英文关键词分别排在中英文摘要下方。 2.“摘要（Abstract）”和“关键词（Key Words）”字样后加冒号（：）左顶格排（小5号黑体），转行文字顶格排。四要素名称“目的（Objective）”“方法（Methods）”“结果（Results）”“结论（Conclusion）”文字均为小5号黑体，后空1字格排；其余文字为小5号宋体。多个关键词之间隔以“；”。 3.中文摘要与作者姓名行间距空5号字1行。 四、中图分类号、文献标志码、文章编号 中图分类号、文献标志码、文章编号排在中文关键词下方、英文文题上方，无须标注英文分类号。“中图分类号”、“文献标志码”、“文章编号”后加冒号“：”，用小5号黑体排，其余文字均为小5号宋体。 五、英文文题、作者姓名及单位 1.英文文题用4号黑正体左顶格排，文题首字母大写，其余字母均小写。 2.英文摘要中作者姓名在英文文题下另起一行左顶格排，用小5号白正体居中排。作者姓名后在圆括号内用小5号白斜体接排作者单位。英文摘要内容与作者名间无行空。 3.英文文题与中图分类号、文献标志码、文章编号的行间距空5号字1行 六、基金项目 1. 文章首页地脚半栏排“基金项目：”用6号字黑体顶左排，其余文字为6号宋体。用横细线与正文分开。“基金项目：”左上角加“﹡”号。 2.在圆括号内注明其项目编号。多项基金应依次列出，其间以“；”隔开，连排，
认识一个朋友，他对有机化学投稿十分有经验，最近有幸邀请到他谈了谈对有机化学高档次期刊投稿过程中的一些看法和意见，十分的给力，希望能对小木虫上学有机化学乃至化学的同仁们起到一定帮助。再次感谢这位友人的热情应邀。 在小木虫潜水多年，也获益非浅。抽空写了如下的个人感受，希望对大家有所帮助。 曾经见过的JACS和ANGEW CHEM投稿不下50 篇.其他化学2区的文章投稿可能就更多了.总而言之,看过的审稿意见不下100 篇。下面就我的所见，总结一下我对有机化学投稿的一些个人看法。主要是JACS, ORG LETT。只是个人的感受，如有失偏颇，敬请原谅。其次文章写的比较流水，大家轻拍。 虽然主题是有机化学杂志投稿，但我认为对其他专业的期刊投稿也都很有借鉴意义。 1. JACS和ANGEW CHEM比较 许多人可能都知道,JACS (IF=是纯化学期刊中的老大(CNS除外).虽然影响因子(IF)没有ANGEW CHEM (IF=12)高,但由于ANGEW CHEM只有通讯无全文(一般通讯的引用次数会比全文的期刊高:如ORG LETT比JOC高; ANGEW CHEM比其全文的CHEM. EUR. J.高,等等 ),还有ANGEW CHEM有REVIEW ARTICL (REVIEW的引用次数一般都很高,如CHEM. REVIEW, ACC. CHEM. RES., CHEM. SOC. REV. ), 还有ANGEW CHEM有德文版本(会有双重引用). 可能很多人认为JACS比ANGEW CHEM难中.但我不完全这么认为.毕竟文章能否接收和很多因素有关.虽然的确有一些JACS拒掉的文章改投ANGEW CHEM却接受了(我见过4篇左右).但我也有见过很多投JACS没有中的,投ANGEW CHEM也没有中.而一些投ANGEW CHEM没有中的,改投JACS却反而被接收了(我见过的3篇).但总体来说,可能ANGEW CHEM中的发表的有机化学的文章比例比JACS中的比例高,所以可能ANGEW CHEM接收可能还是会比JACS简单一点. 2. JACS很难投中 JACS很难投中,他对工作的新颖性要求很高.最近几年由于JACS偏重材料和生物化学,所以有机的想发JACS, 难度就更大了. 现在JACS每年收到的稿件太多,且逐年增长,所以他们肯定会尽量来拒你的稿子,拒稿率高于80%.很多很优秀的有机合成工作最后只能在ORG LETT, CHEM COMMUN, CHEM EUR J, JOC, ADV. SYNTH. CATAL.等杂志上发表. 我有一个朋友,他是负责HIGHLIGHT化学期刊上的优秀的研究工作的.有一次他就说:ORG LETT上有些工作很好,但由于有些审稿人员太STUPID,所以JACS被拒了,最后只能无奈改投并发表在ORG LETT. 一般我们看到发在JACS上的有机合成工作,大部分都集中于不对称催化和过渡金属催化的有机反应两个领域. 所有如果能向这两个方向靠的话,JACS可能会容易发一些.
国际期刊投稿程序实例 The Journal of Encapsulation and Adsorption Sciences(封装与吸附JEAS)is an international open access（开放读取）journal dedicated to reporting on the latest advances in describing scientific and technological advances that cover the basic sciences, engineering aspects and applied technology of molecules (proteins, enzymes酶, food, fragrance香料, gas...) as well as other diverse materials encapsulation and adsorption with preparative manipulation and related materials properties. Due to the open access publishing model, papers published in JEAS gain a better visibility You are invited to submit papers in the following areas: Biomedical and pharmaceutical（制药applications with drug delivery systems药物释放(transdermal经皮给药, oral口服), biomarkers生物标记, nanomedicine, nano-taggants纳米标签with fluorescent dyes encapsulated,荧光染色分装 theranostics, biomimetics... Food technology Cosmetics 化妆，美容 Textiles 纺织 Biochemistry 生化技术 Optics 光学 Photonics 光子学 Environment,环境energy storage,贮能thermal insulation隔热and reinforcement 增强materials Hydrogels水凝胶, polymers聚合物，高分子材料, (sol-gel) glasses, ceramics, inor ganic-organic hybrid materials无机有机杂化材料, porous materials多孔材料and metal-organic framework as bulk or films金属有机主体基材或薄膜材料, multi-fun ctional particles多功能材料nanocapsules,纳米胶囊and any other host matrices and materials supports of interest. Coating process of encapsulated materials Bioencapsulation Bioadsorption Controlled Release 可控释放 Molecular interactions studies, surface properties Technical processes and analytical methods Editor in Chief主编 Editorial Board编委会 Authors' Guidelines General Information
《中医杂志》稿约 《中医杂志》是由国家中医药管理局主管，中华中医药学会、中国中医科学院主办的国家级综合性中医药学术期刊。办刊宗旨是发扬中医特色,以中医学术为本,促进中医现代化和中西医结合事业的发展,提高为主,兼顾普及,面向临床,兼重基础理论,努力促进中医药和中西医结合学术的交流与发展。2011年起改为半月刊，每期96页，国内外公开发行。 1 主要栏目 2011年《中医杂志》对栏目进行了部分调整，将涉及临床的研究报告归属“临床论著”，而采用动物实验的研究报告归属“实验研究”，使栏目设置更趋合理、清晰。调整后的主要栏目有：专家论坛、学术探讨、当代名医、思路与方法、中医药发展园地、方法学与临床评价、临床论著、实验研究、文献研究、临床报道、临证心得、专题笔谈、综述、百家园、标准与规范、学术争鸣、病例讨论、中医教育、海外中医、临床解惑、名医医案、学术动态等，其中专题笔谈、病例讨论、中医教育、海外中医、临床解惑等栏目只在上半月刊出。 2 稿件要求 稿件内容应具有科学性、创新性和实用性，资料应真实可靠，数据准确，论点明确，文字精炼，层次清楚。理论论述、临床及实验研究报告、综述等稿件一般不超过6000字,临床报道及其他类稿件一般不超过3000字。除专题笔谈及临床解惑栏目外，其余稿件均要求根据稿件内容标注参考文献，每篇稿件参考文献数量应不少于5条。 2.1文题 文题应简明扼要，重点突出。一般以20个汉字以内为宜，尽量不用缩略语。 2.2 基金项目 论文涉及基金项目者应注明项目名称及编号。基金项目名称应按国家有关部门规定的正式名称书写，并须附基金项目证明复印件。 2.3 著者 著者姓名在文题下按序排列,排序应在投稿时确定，稿件修改及编排过程中一般不宜再做更改。确需变更时必须出具由全体著者签名的书面证明并加盖有关单位公章。来稿时应注明著者职称、主要研究方向、所属单位全称、所在科室及详细地址、邮政编码、联系电话；1个以上著者时请注明通讯作者姓名及联系方式（电子信箱、电话号码）。 2.4 摘要及关键词 论著类稿件须附中文摘要,其中临床研究、实验研究论著应按照目的、方法、结果、结论的结构编写摘要,字数以200字左右为宜。其他论著应附指示性摘要。正文前需标出3～8个关键词。 2.5 数字与计量单位 数字用法执行《关于出版物上数字用法的规定》（GB/T 15835-1995）。物理量量值必须用阿拉伯数字，并正确使用法定计量单位。如：150km、600mg、39℃等。计量单位实行中华人民共和国国家标准《国际单位制及其应用》（GB3100-1993）。 2.6 统计学符号 按《统计学名词及符号》（GB3358-82）的有关规定书写,常用符号举例如下：样本的算术平均数用英文小写m(中位数用M)；标准差用英文小写s；标准误用英文小写s；t检验用英文小写t；F检验用英文大写F；卡方检验用希文小写χ２；相关系数用英文小写r；自由度用希文小写ν；概率用英文大写P(P值前应给出具体检验值,如t值、χ２值、q值等)。以上符号均用斜体。 2.7 图表
CARBON――Guide for Authors(作者指南) 《Carbon》是Elsevier和美国碳学会（American Carbon Society）合办的一个国际学术刊物。 稿件的准备 所有作者在投稿之前均被要求认真阅读“投稿检查表”（Carbon Submission Checklist）如果发现一个稿件中“投稿检查表”所列项目有问题的话，该稿件将被退回给作者，请作者修改后再重新投稿。 概述 所有稿件都必须是计算机文字软件处理、双倍行距、具有足够宽的页边距和使用12 pt大小的文字（推荐使用Times New Roman）。通讯作者需用*号标识，并在第一页以页底脚标的形式给出详细的联系方式（传真号和电子邮件地址）。必须给出所有作者的完整通信地址和所属单位。为了保持刊物格式的一致性，编辑将保留进行格式更改的权利。 稿件的种类 Carbon接受三种类型的稿件，每一种都有其单独的格式。 编辑快报（Letters to the Editor） “编辑快报”发表简短的通讯，长度不超过5页（双行间距，含参考文献）、不得超过5个图/表，建议最多不引用10个参考文献。一篇“编辑快报”应包括不超过100字的摘要，并且不分章节。提供的图表大小需适合缩小到杂志中的一个单列宽度（约85毫米）。“编辑快报”必须是：（a）一个简洁的研究报告；（b）对已在
Carbon上发表的其他论文进行评述。 研究论文（Research Papers） “研究论文”可以是任意长度的论文，应包括不超过200字的摘要，并分为用数字标明的如下所述的章节。 综合评述（Review Articles） “综合评述”一般由编辑邀请撰写，我们强烈建议你在投稿“综合评述”之前先与主编联系。“综合评述”需就一个当前十分重要的研究主题或方向给予全面、系统、反映最新进展的评述，格式与“研究论文”相同，但需要在摘要之后立即给出一个目录。 请注意：所有论文都是即期发表，“编辑快报”并无优先权。目前一篇论文从接受发表到上网（On-line）的平均时间为6天，而任一编辑认为特别重要的论文则只需要2天时间。 摘要：所有论文均需提供摘要。“编辑快报”的摘要不超过100字，而其他论文的摘要不超过200字。在“编辑快报”中一定要用一水平线或空一行将摘要和内容分开。 内容(Text)：在写作原稿时请采用如下次序：题目、作者、作者单位、摘要、（请注意，Carbon已不再使用关键词）、主要内容(包含插入的图和表格)、致谢、附录和参考文献。所有其他脚注（表格的脚注和通讯作者联系方式的脚注除外）必须用阿拉伯数字用上角标注明。只有所用方法是新方法时，才应该在论文中对此 方法作较为详细的描述。图和表格应该插入到论文内容中的适当位置（在相关介绍之后）。 章节（Sections）：章节必须用阿拉伯数字排序，用小数点系统对章节下的小标题
《中华口腔医学杂志》 最新投稿须知约稿指南 期刊简介：《中华口腔医学杂志》为中华医学会主办的口腔医学专业学术期刊，以广大口腔医师为主要读者对象，报道口腔医学领域领先的科研成果和临床诊疗经验，以及对口腔临床有指导作用、且与口腔临床密切结合的基础理论研究。栏目：设有论著、论著摘要、病例报告、急诊经验、综合报道、经验与教训、技术交流、讲座、综述、会议纪要、临床病理（病例）讨论、国内外学术动态、医学见闻等栏目。 宗旨：贯彻党和国家的卫生工作方针政策，贯彻理论与实践、普及与提高相结合的方针，反映我国口腔临床科研工作的重大进展，促进国内外口腔学术交流。投稿须知 投稿方式电子邮件投稿（即网络投稿）请用Word格式的附件来邮；邮寄来稿请尽量用小四号字打印在A4纸上，凡字迹潦草、涂改不清的稿件，恕不受理。 来稿须附单位推荐信（电子邮件投稿请拍照后以JPG格式的附件来邮），作者单位对文稿的真实性和保密性负责，并声明未一稿两投、不涉及保密、署名无争议等项，并注明第一作者姓名、性别、学历、职称、职务、单位、地址及邮码务必写清楚。多作者稿署名时须征得其他作者同意，排好先后次序，接《稿件录用通知书》后不再进行改动。
为加快稿件处理速度、提高工作效率，条件允许的作者请尽量优先选择电子邮件的方式投稿，本刊全国统一投稿电子邮箱E-mail：zhkqyxzz@https://www.doczj.com/doc/ee15950511.html, 。请作者尽量勿选择邮寄稿件，以免遗失或延误时间。热忱欢迎广大读者踊跃投稿和订阅。 文字要求来稿应具有实用性、先进性、科学性和逻辑性，要求资料真实、论点明确、结构严谨、层次清楚、文字精炼、数据准确，必要时应做统计学处理。论著、综述类一般不超过5000字，经验交流不超过3000字，简报、病例报告不超过2000字。邮寄稿件请作者以A4纸张打印并核对清楚，尤其标点符号，标点符号占一格，英文应隔行打印。为提高审稿效率，条件允许的作者请优先选择电子邮件的方式投稿。不准一稿多投，文责自负，自留底稿，一律不退。 文题：力求简明、醒目，反映文章的主题。中文文题一般以20个汉字以内为宜。 摘要：论著须附中、英文摘要，摘要必须包括目的、方法、结果（应给出主要数据）、结论四部分，各部分冠以相应的标题。采用第三人称撰写，不用“本文”、“作者”等主语。考虑到我国读者可参考中文原著资料，为节省篇幅，中文摘要可简略些（200字左右），英文摘要则相对具体些（400个实词左右）。英文摘要尚应包括文题、作者姓名（汉语拼音）、单位名称、所在城市名、邮政编码及国籍。英文摘要中应列出全部作者的姓名；不属同一单位时，在第一作者姓名右上角加“*”，同时在单位名称首 字母左上角加“*”。 关键词：论著需标引2-5个关键词。请尽量使用美国国立医学图书馆编辑的最新版《Index Medicus》中医学主题词表（MeSH）内所列的词。如果最新版